Aimmune Therapeutics (AIMT) – Analyst Ratings
-
Cantor Fitzgerald Downgrades Aimmune Therapeutics (AIMT) to Neutral
-
Wedbush Downgrades Aimmune Therapeutics (AIMT) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AIMT Stock Lookup